Mita Tomoya, Katakami Naoto, Shiraiwa Toshihiko, Yoshii Hidenori, Gosho Masahiko, Shimomura Iichiro, Watada Hirotaka
Department of Metabolism & Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
J Diabetes Investig. 2017 Mar;8(2):254-255. doi: 10.1111/jdi.12559.
Figure 1 shows differences in treatment-induced delta change in carotid IMT relative to baseline, according to various pre-defined risk factors for atherosclerosis. These data suggest that treatment with DPP-4 inhibitors seem to prevent the progression of carotid atherosclerosis regardless of disease burden.
图1显示了根据动脉粥样硬化的各种预定义风险因素,治疗引起的颈动脉内膜中层厚度相对于基线的变化差异。这些数据表明,无论疾病负担如何,使用二肽基肽酶-4抑制剂进行治疗似乎都能预防颈动脉粥样硬化的进展。